BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18889)

  • 1. Regulation of dopamine-dependent adenylate cyclase by a Ca++ binding protein stored in synaptic membranes.
    Costa E; Gnegy M; Revuelta A; Uzunov P
    Adv Biochem Psychopharmacol; 1977; 16():403-8. PubMed ID: 18889
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical regulation and physiological significance of cyclic nucleotides in the nervous system.
    Kebabian JW
    Adv Cyclic Nucleotide Res; 1977; 8():421-508. PubMed ID: 21551
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein.
    Gnegy ME; Uzunov P; Costa
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):3887-90. PubMed ID: 186777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calmodulin on catecholamine-linked adenylate cyclase activity in rat striatum and cerebral cortex.
    Gnegy ME; Hultin T; Treisman G
    Adv Biochem Psychopharmacol; 1980; 21():125-31. PubMed ID: 6246737
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of inhibitory actions of chlorpromazine or its 7,8-dihydroxy and 7,8-dioxo-didesmethyl analogs on DA-sensitive adenylate cyclase and calmodulin activation of phosphodiesterase in rat striatum.
    Palmer GC; Pajer KA; Manian AA
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):202-11. PubMed ID: 2988471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase].
    Sobolev AS; Orekhov AN; Dhirkov IuIu; Kudriashov IuB
    Dokl Akad Nauk SSSR; 1975 Sep; 224(3):713-6. PubMed ID: 173507
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
    Levin RM; Weiss B
    Mol Pharmacol; 1977 Jul; 13(4):690-7. PubMed ID: 18661
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of adenylate cyclase among membrane fractions of rat liver.
    Yunghans WN; Morré DJ
    Cytobiologie; 1978 Jun; 17(1):212-31. PubMed ID: 211057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute and chronic administration of phencyclidine on dopaminergic receptors in rat striatum.
    Leelavathi DE; Misra CH; Shelat H; Smith RC
    Commun Psychopharmacol; 1980; 4(5):417-24. PubMed ID: 6277560
    [No Abstract]   [Full Text] [Related]  

  • 10. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 11. Lead perturbs calmodulin dependent cyclic AMP metabolism in rat central nervous system.
    Sandhir R; Gill KD
    Biochem Mol Biol Int; 1994 Jul; 33(4):729-42. PubMed ID: 7981661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
    Wong DT; Reid LR
    Commun Psychopharmacol; 1980; 4(4):269-75. PubMed ID: 7273702
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
    Olianas MC; Onali P; Neff NH; Costa E
    Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of narcotic dependence and withdrawal on striatal dopamine-sensitive adenylate cyclase and synaptosomal cyclic AMP metabolism.
    Merali Z; Tsang B; Singhal RL; Hrdina PD
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):29-37. PubMed ID: 180579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of denervation on cyclic amp regulating enzymes in the rat gastrocnemius muscle.
    Pacifici GM; Pellegrino C; Maffei C; Beconcini D
    Ital J Biochem; 1981; 30(1):20-9. PubMed ID: 6265404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Di- and trihydroxy analogs of chlorpromazine influence the central activity of adenylate cyclase and cyclic AMP phosphodiesterase.
    Palmer GC; Legendre JL; Manian AA
    Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):59-70. PubMed ID: 6255882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of adenylate cyclase by alcohols requires the nucleotide-binding protein.
    Luthin GR; Tabakoff B
    J Pharmacol Exp Ther; 1984 Mar; 228(3):579-87. PubMed ID: 6707909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.
    Gnegy ME; Lucchelli A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):121-7. PubMed ID: 202883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.